Track papers across labs, topics, and trends.
Search papers, labs, and topics across Lattice.
1
0
0
0
Previous study results support further investigation into efficacy of 177Lu-girentuximab in patients with advanced, relapsed or recurrent ccRCC, and suggest favorable safety, tolerability, and efficacy profile.